Needham Maintains Buy on iRhythm Technologies, Raises Price Target to $179
Needham analyst David Saxon maintains iRhythm Technologies (NASDAQ:IRTC) with a Buy and raises the price target from $135 to $179.
24 Stocks Moving in Friday’s Pre-Market Session
Gainers
Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 35% to $3.47 in pre-market trading. Vinco Ventures set record date as May 18, 2022 For dividend of shares related to Cryptyde deal. The dividend is expected to be distributed on May 27, 2022.
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Analyst Ratings For iRhythm Technologies
Within the last quarter, iRhythm Technologies (NASDAQ:IRTC) has observed the following analyst ratings:
JP Morgan Maintains Overweight on iRhythm Technologies, Raises Price Target to $192
JP Morgan analyst Allen Gong maintains iRhythm Technologies (NASDAQ:IRTC) with a Overweight and raises the price target from $156 to $192.
Needham Upgrades iRhythm Technologies to Buy, Announces $135 Price Target
Needham analyst David Saxon upgrades iRhythm Technologies (NASDAQ:IRTC) from Hold to Buy and announces $135 price target.
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
Here's a roundup of top developments in the biotech space over the last 24 hours.
Stocks In Focus
Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase 2b/3 Study
Earnings Scheduled For February 23, 2022
Companies Reporting Before The Bell
• Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter.